Glioma: all 1,425 studies

Page 6 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.

• Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV GliomaCompletedNCT01290692Phase 2Results posted
• Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent GlioblastomaCompletedNCT01266031Phase 1/2Results posted
• Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade GliomaCompletedNCT01236560Phase 2/3Results posted
• Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine GliomaCompletedNCT01189266Phase 1/2Results posted
• RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant GliomaTerminatedNCT01189240Phase 1/2Results posted
• A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade GliomasCompletedNCT01188096Phase 2Results posted
• Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)TerminatedNCT01182350Phase 2Results posted
• Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade GliomasCompletedNCT01158651Phase 2Results posted
• Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant GliomasCompletedNCT01140568Phase 2Results posted
• A Study in Subjects With Recurrent Malignant GliomaCompletedNCT01137604Phase 2Results posted
• A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem GliomasCompletedNCT01118377Phase 2Results posted
• Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the BrainTerminatedNCT01116661Phase 2Results posted
• AMG 102 and Avastin for Recurrent Malignant GliomaCompletedNCT01113398Phase 2Results posted
• Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade GliomaTerminatedNCT01105702Phase 2Results posted
• Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaTerminatedNCT01095094Phase 2Results posted
• Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV GliomaCompletedNCT01081223Phase 1/2Results posted
• Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseTerminatedNCT01068782Phase 2Results posted
• Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT01051557Phase 1/2Results posted
• Panitumumab and Irinotecan for Malignant GliomasTerminatedNCT01017653Phase 2Results posted
• Radiosurgery and Avastin for Recurrent Malignant GliomasCompletedNCT01017250Not applicableResults posted
• Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for GlioblastomaCompletedNCT01004874Phase 2Results posted
• Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & TemozolomideCompletedNCT00990652Phase 2Results posted
• Image-Guided Stereotactic Biopsy of High Grade GliomasCompletedNCT00979810Not applicableResults posted
• Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)CompletedNCT00953121Phase 2Results posted
• Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant GliomasCompletedNCT00939991Phase 1/2Results posted
• Sunitinib to Treat Recurrent Brain CancerTerminatedNCT00923117Phase 2Results posted
• Intravenous Palonosetron With Radiotherapy and Concomitant TemozolomideCompletedNCT00900757Phase 2Results posted
• Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma MultiformeCompletedNCT00892177Phase 2Results posted
• Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine GliomaCompletedNCT00879437Phase 2Results posted
• LBH589 and Bevacizumab in Patients With Recurrent High Grade GliomaCompletedNCT00859222Phase 1/2Results posted
• Everolimus in Treating Patients With Recurrent Low-Grade GliomaCompletedNCT00823459Phase 2Results posted
• Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade GliomaCompletedNCT00795665Phase 2Results posted
• Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant GliomaCompletedNCT00782756Phase 2Results posted
• Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade GliomasCompletedNCT00782626Phase 2Results posted
• Vaccination-Dendritic Cells With Peptides for Recurrent Malignant GliomasCompletedNCT00766753Phase 1/2Results posted
• A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant GliomasCompletedNCT00766467Phase 2Results posted
• A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)TerminatedNCT00735436Phase 2Results posted
• BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant GliomaCompletedNCT00727506Phase 2Results posted
• Study of Capecitabine to Treat Recurrent High Grade GliomasCompletedNCT00717197Phase 2Results posted
• Late Effects of Proton Radiation Therapy in Patients With Low-Grade GliomaCompletedNCT00681473Not applicableResults posted
• Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyCompletedNCT00679354Phase 2Results posted
• Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma MultiformeCompletedNCT00672243Phase 2Results posted
• Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)CompletedNCT00671970Phase 2Results posted
• O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant GliomasTerminatedNCT00669669Phase 1/2Results posted
• Temozolomide in Treating Patients With Recurrent High-Grade GliomaCompletedNCT00619112Phase 2Results posted
• Phase II Avastin + Bortezomib for Patients With Recurrent Malignant GliomaCompletedNCT00611325Phase 2Results posted
• Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant GliomasCompletedNCT00590954Phase 2Results posted
• Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant GliomaCompletedNCT00589875Phase 2Results posted
• Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant GliomasCompletedNCT00586508Phase 2Results posted
• A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed GliomasCompletedNCT00532948Phase 1Results posted
• 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma PatientsCompletedNCT00504660Phase 2Results posted
• Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant GliomaCompletedNCT00501891Phase 2Results posted
• Sunitinib in Treating Patients With Recurrent Malignant GliomasCompletedNCT00499473Phase 2Results posted
• Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant GliomaCompletedNCT00498927Phase 2Results posted
• Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerCompletedNCT00492089Phase 2Results posted
• A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent GliomaTerminatedNCT00479765Phase 1/2Results posted
• Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)CompletedNCT00424554Phase 2Results posted
• Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With GliomasCompletedNCT00412542Phase 2Results posted
• Combination of Irinotecan and Temozolomide in Children With Brain Tumors.CompletedNCT00404495Phase 2Results posted
• Bevacizumab and Irinotecan to Treat Brain TumorsTerminatedNCT00393094Phase 2Results posted
• The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)CompletedNCT00392171Phase 2Results posted
• Viral Therapy in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00390299Phase 1Results posted
• Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine GliomaCompletedNCT00387790Phase 2Results posted
• Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade GliomaCompletedNCT00381797Phase 2Results posted
• VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to TemozolomideCompletedNCT00369590Phase 2Results posted
• Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and OligodendrogliomasTerminatedNCT00360828Phase 2Results posted
• Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant GliomaCompletedNCT00350727Phase 2Results posted
• A Pilot Study of Dronabinol for Adult Patients With Primary GliomasCompletedNCT00314808Phase 1Results posted
• Temozolomide in Treating Patients With Low-Grade GliomaCompletedNCT00313729Phase 2Results posted
• Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain TumorsCompletedNCT00302159Phase 2Results posted
• Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)TerminatedNCT00290771Phase 2Results posted
• O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem TumorsCompletedNCT00275002Phase 2Results posted
• Bevacizumab for Recurrent Malignant GliomaCompletedNCT00271609Phase 2Results posted
• Radiation Therapy in Treating Young Patients With GliomasCompletedNCT00238264Phase 2Results posted
• Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/GlioblastomaCompletedNCT00200161Phase 2Results posted
• Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed GliomaCompletedNCT00124657Phase 1/2Results posted
• Temozolomide and Radiation Therapy in Treating Patients With GliomasCompletedNCT00114140Phase 2Results posted
• Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant GliomaCompletedNCT00112736Phase 1/2Results posted
• Tamoxifen and Bortezomib to Treat Recurrent Brain TumorsCompletedNCT00108069Phase 2Results posted
• Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral MetastasesCompletedNCT00103038Not applicableResults posted
• Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System TumorsCompletedNCT00095940Phase 1/2Results posted
• Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem GliomaCompletedNCT00079339Phase 1/2Results posted
• Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade GliomaCompletedNCT00077207Not applicableResults posted
• Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic GliomaCompletedNCT00058123Phase 2Results posted
• Imatinib Mesylate in Treating Patients With Recurrent Brain TumorCompletedNCT00049127Phase 1/2Results posted
• Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent GliomasCompletedNCT00047879Phase 2Results posted
• Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive MeningiomaCompletedNCT00045110Phase 1/2Results posted
• Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed GliomasCompletedNCT00042991Phase 1/2Results posted
• A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine GliomasCompletedNCT00036569Phase 2Results posted
• Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent GliomaTerminatedNCT00021229Phase 1/2Results posted
• Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade GliomaTerminatedNCT00003535Phase 2Results posted
• Antineoplaston Therapy in Treating Children With Visual Pathway GliomaCompletedNCT00003477Phase 2Results posted
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed GliomasCompletedNCT00003473Phase 2Results posted
• Antineoplaston Therapy in Treating Patients With Brain Stem GliomaCompletedNCT00003459Phase 2Results posted
• The Clinical Application Value of CAIX-Targeted PET Hypoxia Imaging in Malignant TumorsActive, not recruitingNCT07890038
• 3D-ASL and TDD-MRI for True Progression and Pseudoprogression After Glioma SurgeryActive, not recruitingNCT07687277
• GliomaAI-Oligo: MRI-Based Detection of IDH Mutant OligodendrogliomaCompletedNCT07673705
• GliomaAI-GBM: MRI-Based Detection of IDH Wildtype GlioblastomaCompletedNCT07673692
• GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4CompletedNCT07673679
• GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3)CompletedNCT07673666

← Glioma overview